Ooi EE - Search Results

1

Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children.

Zhong Y, Kang AYH, Tay CJX, Li HE, Elyana N, Tan CW, Yap WC, Lim JME, Le Bert N, Chan KR, Ong EZ, Low JG, Shek LP, Tham EH, Ooi EE. Zhong Y, et al. Among authors: ooi ee. Nat Med. 2024 May;30(5):1373-1383. doi: 10.1038/s41591-024-02962-3. Epub 2024 Apr 30. Nat Med. 2024. PMID: 38689059 Free PMC article.

2

Early Dengue infection and outcome study (EDEN) - study design and preliminary findings.

Low JG, Ooi EE, Tolfvenstam T, Leo YS, Hibberd ML, Ng LC, Lai YL, Yap GS, Li CS, Vasudevan SG, Ong A. Low JG, et al. Among authors: ooi ee. Ann Acad Med Singap. 2006 Nov;35(11):783-9. Ann Acad Med Singap. 2006. PMID: 17160194 Free article.

3

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.

Chan KR, Zhang SL, Tan HC, Chan YK, Chow A, Lim AP, Vasudevan SG, Hanson BJ, Ooi EE. Chan KR, et al. Among authors: ooi ee. Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12479-84. doi: 10.1073/pnas.1106568108. Epub 2011 Jul 11. Proc Natl Acad Sci U S A. 2011. PMID: 21746897 Free PMC article.

4

Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model.

Rathore AP, Paradkar PN, Watanabe S, Tan KH, Sung C, Connolly JE, Low J, Ooi EE, Vasudevan SG. Rathore AP, et al. Among authors: ooi ee. Antiviral Res. 2011 Dec;92(3):453-60. doi: 10.1016/j.antiviral.2011.10.002. Epub 2011 Oct 12. Antiviral Res. 2011. PMID: 22020302

5

Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection.

Balakrishnan T, Bela-Ong DB, Toh YX, Flamand M, Devi S, Koh MB, Hibberd ML, Ooi EE, Low JG, Leo YS, Gu F, Fink K. Balakrishnan T, et al. Among authors: ooi ee. PLoS One. 2011;6(12):e29430. doi: 10.1371/journal.pone.0029430. Epub 2011 Dec 22. PLoS One. 2011. PMID: 22216280 Free PMC article.

6

Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial.

Watanabe S, Rathore AP, Sung C, Lu F, Khoo YM, Connolly J, Low J, Ooi EE, Lee HS, Vasudevan SG. Watanabe S, et al. Among authors: ooi ee. Antiviral Res. 2012 Oct;96(1):32-5. doi: 10.1016/j.antiviral.2012.07.008. Epub 2012 Jul 31. Antiviral Res. 2012. PMID: 22867971

7

Neutralization of dengue virus in the presence of Fc receptor-mediated phagocytosis distinguishes serotype-specific from cross-neutralizing antibodies.

Wu RS, Chan KR, Tan HC, Chow A, Allen JC Jr, Ooi EE. Wu RS, et al. Among authors: ooi ee. Antiviral Res. 2012 Dec;96(3):340-3. doi: 10.1016/j.antiviral.2012.09.018. Epub 2012 Oct 4. Antiviral Res. 2012. PMID: 23041143 Free article.

8

Dengue virus neutralization in cells expressing Fc gamma receptors.

Chawla T, Chan KR, Zhang SL, Tan HC, Lim AP, Hanson BJ, Ooi EE. Chawla T, et al. Among authors: ooi ee. PLoS One. 2013 May 22;8(5):e65231. doi: 10.1371/journal.pone.0065231. Print 2013. PLoS One. 2013. PMID: 23717696 Free PMC article.

9

Dengue--old disease, new challenges in an ageing population.

Low JG, Ooi EE. Low JG, et al. Among authors: ooi ee. Ann Acad Med Singap. 2013 Aug;42(8):373-5. Ann Acad Med Singap. 2013. PMID: 24045371 Free article. No abstract available.

10

Therapeutic antibodies as a treatment option for dengue fever.

Chan KR, Ong EZ, Ooi EE. Chan KR, et al. Among authors: ooi ee. Expert Rev Anti Infect Ther. 2013 Nov;11(11):1147-57. doi: 10.1586/14787210.2013.839941. Epub 2013 Oct 4. Expert Rev Anti Infect Ther. 2013. PMID: 24093625 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page